Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Phio Pharmaceuticals Corp. - Common Stock
(NQ:
PHIO
)
1.090
+0.030 (+2.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
219,683
Open
1.070
Bid (Size)
1.060 (2,000)
Ask (Size)
1.090 (400)
Prev. Close
1.060
Today's Range
1.070 - 1.095
52wk Range
0.8127 - 4.190
Shares Outstanding
5,726,750
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
Today 7:00 EDT
King of Prussia, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing...
Via
Newsfile
Topics
Intellectual Property
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
August 06, 2026
Strategic milestone advancements for lead clinical candidate PH-762 Initiation of commercial scale API, long term non-clinical toxicology, completion of Phase...
Via
Newsfile
Performance
YTD
N/A
N/A
1 Month
+9.0%
+9.0%
3 Month
+0.9%
+0.9%
6 Month
+21.1%
+21.1%
1 Year
-48.8%
-48.8%
More News
Read More
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
July 22, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
July 22, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
July 21, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
July 15, 2026
Via
Newsfile
Topics
Intellectual Property
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
June 26, 2026
Via
Newsfile
Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026
June 25, 2026
Via
Newsfile
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
June 24, 2026
Via
Newsfile
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
June 18, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
May 26, 2026
Via
Newsfile
Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
May 12, 2026
Via
Newsfile
Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
May 07, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
April 23, 2026
Via
Newsfile
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
April 13, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
April 09, 2026
Via
Newsfile
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
March 30, 2026
Via
Newsfile
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
March 23, 2026
Via
Newsfile
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
March 16, 2026
Via
Newsfile
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
March 10, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
March 10, 2026
Via
Newsfile
Frequently Asked Questions
Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.090
When was Phio Pharmaceuticals Corp. - Common Stock last traded?
The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 08/11/26 04:00 PM ET
What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 6.24M
How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
Phio Pharmaceuticals Corp. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.